Afinitor Approved In Europe For Advanced Breast Cancer Medical News Today E.U. approval has been granted to Novartis drug AfinitorĀ® (everolimus) after successful completion of the Phase III BOLERO-2 (Breast cancer trials of OraL EveROlimus-2) trial. Afinitor tablets have been approved for the treatment of hormone receptor ... |
